
Halena Leah Marcelin, PHARMD, MS, BCPS
Articles by Halena Leah Marcelin, PHARMD, MS, BCPS


The 340B program launched in 1992 to “stretch scarce federal resources” in order for participating entities to increase accessibility to care (eg, medications, clinical services, etc) for patients.

The 340B Drug Pricing Program began in 1992 with the intent of permitting covered entities “to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.”

Since its induction in 1992, the 340B Drug Pricing Program has been responsible for helping eligible covered entities stretch scarce federal resources and increase services to patients of the covered entity.
Latest Updated Articles
340B Compliance: Tips to Maintaining a Successful ProgramPublished: November 23rd 2016 | Updated:
340B Maintenance: Keys to Maintaining Your 340B Program Software to Ensure a Compliant ProgramPublished: April 16th 2017 | Updated:
340B Audit: Building a Self-Audit ProgramPublished: May 16th 2017 | Updated:
Minimizing WAC Exposure to Decrease Drug Expense in the Virtual Inventory SettingPublished: May 19th 2018 | Updated:





